Price $14.08 |
Market Cap
2.24B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.89
|
P/S
1.37
|
Dividend %
-
|
|
P/CF
26.8
|
P/FCF
31.7
|
Op. Cash Flow
84.2K
|
FCF
0.4
|
|
Op. Margin
-2.60%
|
Net Margin
-2.80%
|
ROE
-3.70%
|
ROI
-0.20%
|
|
ROA
-1.50%
|
EPS Growth
-124.00%
|
Current Ratio
0.7
|
Debt/Equity
42.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $3.89 | - | - | 147.3M | Strong Buy |
| Medicure Inc (MCUJF) | $0.64 | - | - | 6.1M | Strong Buy |
| Palatin Technologies, Inc. (PTN) | $0.45 | - | - | 101.7M | Strong Buy |
| IRIDEX Corporation (IRIX) | $1.88 | - | - | 23.6M | Strong Buy |
| American Bio Medica Corporatio (ABMC) | $0.12 | - | - | 3.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
